Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

BACKGROUND: Although atrial fibrillation (AF) guidelines indicate that pharmacologic blockade of the renin-angiotensin system may be considered for primary AF prevention in hypertensive patients, previous studies have yielded conflicting results. We sought to determine whether randomization to lisin...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Circ Arrhythm Electrophysiol
Asıl Yazarlar: Dewland, Thomas A., Soliman, Elsayed Z., Yamal, Jose-Miguel, Davis, Barry R., Alonso, Alvaro, Albert, Christine M., Simpson, Lara M., Haywood, L. Julian, Marcus, Gregory M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728652/
https://ncbi.nlm.nih.gov/pubmed/29212812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCEP.117.005463
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller